What is the recommended acute management for a symptomatic patient with severe hyponatraemia (serum sodium <120 mmol/L) presenting with confusion, seizures, severe headache, vomiting, or coma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Severe Hyponatremia Management

For a symptomatic patient with severe hyponatremia (serum sodium <120 mmol/L) presenting with confusion, seizures, severe headache, vomiting, or coma, immediately administer 3% hypertonic saline with a target correction of 6 mmol/L over the first 6 hours or until severe symptoms resolve, while ensuring total correction does not exceed 8 mmol/L in any 24-hour period. 1

Immediate Emergency Management

Initial Bolus Administration

  • Administer 100 mL boluses of 3% hypertonic saline intravenously over 10 minutes, which can be repeated up to three times at 10-minute intervals until severe neurological symptoms improve 1
  • This approach is specifically indicated for patients presenting with confusion, seizures, coma, severe headache, vomiting, or respiratory distress 1, 2
  • The goal is to raise serum sodium by approximately 1-2 mmol/L per hour during the initial emergency phase 3

ICU Admission and Monitoring

  • Admit to intensive care unit for close monitoring during active correction 1
  • Check serum sodium every 2 hours during the initial correction phase for patients with severe symptoms 1
  • After severe symptoms resolve, continue monitoring every 4 hours 1

Critical Correction Rate Guidelines

Standard Correction Limits

  • Maximum correction of 8 mmol/L in any 24-hour period to prevent osmotic demyelination syndrome 1, 4
  • Target correction of 6 mmol/L over the first 6 hours, which means only 2 mmol/L additional correction is permitted in the remaining 18 hours 1
  • Do not aim for normonatremia acutely—the therapeutic goal is 125-130 mmol/L, not the normal range 1

High-Risk Populations Requiring Slower Correction

  • Patients with advanced liver disease, chronic alcoholism, malnutrition, severe hyponatremia, or prior hepatic encephalopathy require even more cautious correction at 4-6 mmol/L per day, maximum 8 mmol/L in 24 hours 1, 4
  • These patients have a 0.5-1.5% risk of osmotic demyelination syndrome even with careful correction 1

Treatment Based on Volume Status

After Initial Stabilization

Once severe symptoms are controlled, determine the underlying etiology based on volume status:

For Hypovolemic Hyponatremia:

  • Discontinue diuretics immediately 1
  • Administer isotonic saline (0.9% NaCl) for volume repletion at 15-20 mL/kg/h initially, then 4-14 mL/kg/h based on response 1
  • Urine sodium <30 mmol/L predicts good response to saline infusion 1

For Euvolemic Hyponatremia (SIADH):

  • After symptom resolution, implement fluid restriction to 1 L/day 1
  • If no response to fluid restriction, add oral sodium chloride 100 mEq three times daily 1
  • Consider vasopressin receptor antagonists (tolvaptan 15 mg once daily) for resistant cases 1

For Hypervolemic Hyponatremia (cirrhosis, heart failure):

  • Implement fluid restriction to 1-1.5 L/day for sodium <125 mmol/L 1
  • Consider albumin infusion in cirrhotic patients 1
  • Avoid hypertonic saline unless life-threatening symptoms are present, as it may worsen ascites and edema 1

Special Considerations for Neurosurgical Patients

Distinguishing Cerebral Salt Wasting from SIADH

  • In neurosurgical patients, cerebral salt wasting (CSW) is more common than SIADH and requires opposite treatment 1
  • CSW is characterized by true hypovolemia with CVP <6 cm H₂O, high urine sodium >20 mmol/L despite volume depletion, and evidence of extracellular volume depletion 1
  • Never use fluid restriction in CSW—this worsens outcomes and can precipitate cerebral ischemia 1

Treatment of CSW

  • Aggressive volume and sodium replacement with isotonic or hypertonic saline (50-100 mL/kg/day) 1
  • For severe symptoms, add fludrocortisone 0.1-0.2 mg daily 1
  • In subarachnoid hemorrhage patients at risk of vasospasm, never use fluid restriction—consider hydrocortisone to prevent natriuresis 1

Management of Overcorrection

If Sodium Rises Too Rapidly

  • If correction exceeds 8 mmol/L in 24 hours, immediately discontinue hypertonic saline 1
  • Switch to D5W (5% dextrose in water) to relower sodium levels 1
  • Consider administering desmopressin to slow or reverse the rapid rise 1
  • Target is to bring the total 24-hour correction back to ≤8 mmol/L from baseline 1

Common Pitfalls to Avoid

  • Never correct chronic hyponatremia faster than 8 mmol/L in 24 hours—this causes osmotic demyelination syndrome with dysarthria, dysphagia, oculomotor dysfunction, and quadriparesis typically 2-7 days after rapid correction 1, 4
  • Do not delay treatment while pursuing diagnostic workup—treat severe symptoms immediately 5
  • Inadequate monitoring during active correction can lead to overcorrection 1
  • Using fluid restriction as initial treatment for altered mental status from hyponatremia is dangerous—this is a medical emergency requiring hypertonic saline 1
  • Failing to distinguish between SIADH and CSW in neurosurgical patients leads to opposite and potentially harmful treatments 1
  • Mortality in severe hyponatremia remains high at approximately 20%, with sepsis, respiratory failure, and presence of neurologic symptoms predicting poor outcome 6

References

Guideline

Management of Sodium Imbalance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Hyponatremia Symptoms and Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Predictors of outcome in hospitalized patients with severe hyponatremia.

Journal of the National Medical Association, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.